Overview

A Phase 1 Study to Assess the Pharmacokinetics of AZD9977 Administered Alone and in Combination With Itraconazole in Healthy Volunteers

Status:
Completed

Trial end date:
2019-04-01

Target enrollment:

Participant gender:

Summary

This is an open-label, non-randomized, fixed sequence study conducted at a single study center with primary aim to assess the pharmacokinetics (PK) of AZD9977 in healthy volunteers when administered alone and in combination with multiple doses of itraconazole.

Phase:

Phase 1

Details

Lead Sponsor:

AstraZeneca

Treatments:

Hydroxyitraconazole
Itraconazole